CURRENT CLINICAL INTERESTS
Thrombotic disorders, including antiphospholipid syndrome and cancer-associated venous thromboembolism.
CURRENT RESEARCH INTERESTS
Clinical investigation, including outcomes-based and comparative effectiveness research. Main focus: novel oral anticoagulants, warfarin reversal, VTE risk prediction, and perioperative anticoagulation.
Khorana AA, Carrier M, Garcia D, Lee AY. Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):91-91.
Samuelson BT, Glynn E, Holmes M, White AA, Martin DB, Garcia D. Use of a computer-based provider order entry (CPOE) intervention to optimize laboratory testing in patients with suspected heparin-induced thrombocytopenia. Thromb Res. 2015 Nov;136(5):928-31.
Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia D, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE Investigators. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015 Aug 27;373(9):823-33.
Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib SM, Dorian P, Ansell J, Commerford P, Flaker G, Lanas F, Vinereanu D, Xavier D, Hylek EM, Held C, Verheugt FW, Granger CB, Lopes RD. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood. Dec 11;124(25):3692-8, 2014.
Garcia D, Akl EA, Carr R, Kearon C. Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood. 122(5):817-24, 2013.
Garcia D, Barrett YC, Ramacciotti E, Weitz JI. Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants. J Thromb Haemost. 11: 245–52, 2013.
Siegal DM, Garcia D. Anticoagulants in cancer. J Thromb Haemost. 10: 2230–41, 2012.